Health status and health-related quality of life associated with von Willebrand disease

American Journal of Hematology

Volumn 73, Issue 2, 2003, Pages 108-114

  Barr, Ronald D ^a,b   Sek, Julia ^a,c   Horsman, John ^b,d   Furlong, William ^b,d   Saleh, Mahassen ^a   Pai, Mohan ^a,b,c   Walker, Irwin ^a,b,c  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Hamilton Health Sciences   (Canada)

^d Health Utilities Incorporated   (Canada)

Author keywords

Quality of life; Von Willebrand disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING DISORDER; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEROLOGY; SEX DIFFERENCE; STATISTICAL ANALYSIS; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; AGED; CANADA; COGNITION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EMOTIONS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; SEX CHARACTERISTICS; VON WILLEBRAND DISEASE;

EID: 0038285035     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10327     Document Type: Article

References (34)

1. Sadler JE Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000;84:160-174.
2. Association of Hemophilia Clinic Directors of Canada. Hemophilia and von Willebrand's disease. 1. Diagnosis, comprehensive care and assessment. Can Med Assoc J 1995;153:19-25.
3. Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001;97:1915-1919.
4. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL. Quality of life during menstruation in patients with inherited bleeding disorders. Haemophilia 1998;4:836-841.
5. Kouides PA, Phatak PD, Burkert P, et al. Gynaecological and obstetrical morbidity in women with Type 1 von Willebrand disease: results of a patient survey. Haemophilia 2000;6:643-648.
6. Ragni MV, Bontempo FA, Cortese Hassett A. von Willebrand disease and bleeding in women. Haemophilia 1999;5:313-317.
7. Foster PA. The reproductive health of women with von Willebrand disease unresponsive to DDAVP. Results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standarisation Committee of the ISTH. Thromb Haemost 1995;74:784-790.
8. Lee CA. Bleeding problems in women. Br J Haematol 2000;108(Suppl 1):14.
9. Seremetis S. The investigation and management of women with menorrhagia. Br J Haematol 2000;108(Suppl 1):14.
10. Kadir RA. Bleeding disorders and pregnancy. Br J Haematol 2000;108 (Suppl 1):15.
11. White B, Woo YL, Corbally R, et al. von Willebrand's disease in patients presenting with menorrhagia. Br J Haematol 2000;108(Suppl 1):55.
12. Edlund M, Blombeck M, von Schoultz B, Anderson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996;53:234-238.
13. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998;351:485-489.
14. Barr RD, Saleh M, Furlong W, et al. Health status and health-related quality of life associated with hemophilia. Am J Hematol 2002;71: 152-160.
15. Furlong W, Feeny D, Torrance GW. Health Utilities Index (HUI®) procedures manual: algorithm for determining HUI Mark 2(HUI2)/ Mark 3 (HUI3) health status classification levels, health states, single-attribute level utility scores and overall health-related quality of life utility scores, from 15-item self-complete health status questionnaires. Dundas, Ontario, Canada: Health Utilities, Inc.; 2000.
16. Feeny DH, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. PharmacoEconomics 1995;7:490-502.
17. Torrance GW, Furlong W, Feeny DH, Boyle M. Multi-attribute preference functions: Health Utilities Index. PharmacoEconomics 1995;7: 503-520.
18. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multi-attribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care 1996;34: 702-722.
19. Feeny D, Furlong W, Torrance GW, et al. Multi-attribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002;40:113-128.
20. Feeny D, Furlong W, Barr RD. Multi-attribute approach to the assessment of health-related quality of life: Health Utilities Index. Med Pediatr Oncol Suppl 1998;1:54-59.
21. Grootendorst P, Feeny D, Furlong W. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population survey. Med Care 2000;38:290-299.
22. Felder-Puig R, Frey E, Sonnleithner G, et al. German cross-cultural adaptation of the Health Utilities Index and its application to a sample of childhood cancer survivors. Eur J Pediatr 2000;159:283-288.
23. Raat H, Bonsel GJ, Essik-Bot M-L, Landgraf JM, Gemke RJBJ. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 2002;55:67-76.
24. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures. Br Med J 2002;324:1417-1421.
25. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies. Ann Med 2001;33:375-384.
26. Drummond MF. Introducing economic and quality of life measures into clinical studies. Ann Med 2001;33:344-349.
27. Whitton AC, Rhydderch H, Furlong W, Feeny D, Barr RD. Self-reported comprehensive health status of adult brain tumor patients using the Health Utilities Index. Cancer 1997;80:258-265.
28. Eastaugh SR. Willingness to pay in treatment of bleeding disorders. Int J Technol Assess Health Care 2000;16:706-710.
29. Solovieva S. Clinical severity of disease, functional disability and health-related quality of life. Three year follow-up study of 150 Finnish patients with coagulation disorders. Haemophilia 2001;7:53-63.
30. Rozeik C, Scharrer I. Defekt des von Willebrand Faktor-proteins. Gynakologische und psychische Probleme bei Frauen mit von Willebrand-Syndrom. Gynakologische Geburtshilfe 1998;3:70-75.
31. Shapiro D, Donfield SM, Lynn HS, et al. Defining the impact of hemophilia: the academic achievement in children with hemophilia study. Pediatrics 2001;108:E105.
32. Youdim MBH, Yehuda S. The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system. Cell Mol Biol 2000;46:491-500.
33. Bruner AB, Joffe A, Duggan AK, Casella IF, Brandt J. Randomized study of cognitive effects of iron supplementation in non-anemic iron-deficient adolescent girls. Lancet 1996;348:992-996.
34. Patterson AJ, Brown WJ, Roberts DCK. Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Australian women of childbearing age. J Am Coll Nutr 2001;20:337-342.